A Phase 3 Study of VX-445 Combination Therapy in Subjects With Cystic Fibrosis Heterozygous for the F508del Mutation and a Minimal Function Mutation (F/MF)

Completed

Plain-English translation of NCT03525444 on ClinicalTrials.gov ↗ · Source last updated May 2020 · How we translate trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(115 sites)

United States

Banner University of Arizona Medical Center, Tucson, Arizona

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Miller Children's Hospital/ Long Beach Memorial, Long Beach, California

Children's Hospital Los Angeles, Los Angeles, California

Valley Children's Hospital/ Children's Hospital of Central California, Madera, California